Immunic (IMUX) Earnings Analysis
Immunic (IMUX) next reports earnings on 2026-08-06, consensus EPS -1.17556 USD. Last quarter (2026-02-26) it missed with EPS -1.2 USD vs -0.9 USD est (-33.3%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -2.53.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IMUX next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -1.17556 USD |
| Revenue estimate | n/a |
IMUX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -1.2 USD | -0.9 USD | -33.3% | Miss |
| 2025-11-13 | -0.13 USD | -0.18 USD | +27.8% | Beat |
| 2025-05-15 | -0.25 USD | -0.25 USD | 0% | Beat |
| 2025-03-31 | -0.25 USD | -0.22 USD | -13.6% | Miss |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
IMUX valuation and analyst view
| Trailing P/E | -2.53 |
|---|---|
| Trailing EPS | -3.46051 USD |
| Price / book | 3.01 |
| Dividend yield | 0.00% |
| Market cap | 0.15B |
| Analyst consensus | Buy (10 buy / 2 hold / 0 sell) |
| Avg price target | 20.5 USD |
Related research pages
Frequently asked questions
When is Immunic (IMUX)'s next earnings date?
Immunic is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -1.17556 USD.
Did IMUX beat earnings last quarter?
In its 2026-02-26 report, IMUX posted EPS of -1.2 USD versus a -0.9 USD estimate — a miss of 33.3%.
What is IMUX's earnings track record?
Over the last 4 reported quarters with consensus data, IMUX beat estimates 2 times (50%).
What is IMUX's current P/E ratio and EPS?
IMUX trades at a trailing P/E of -2.53 on trailing EPS of -3.4605083221165263 USD.
What do analysts rate IMUX?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 20.5 USD.